Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01077583 · ClinicalTrials.gov registry record

Performance Evaluation Study for Clearblue Pregnancy Test

A clinical trial, sponsored by SPD Development Company Limited.

Completed
Registry status
800
Enrollment target

NCT01077583: Completed study, sponsored by SPD Development Company Limited.

NCT01077583 is a clinical trial that has completed, run by SPD Development Company Limited. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01077583 has completed, sponsored by SPD Development Company Limited.

COMPLETED
Registry status
800 participants
Enrollment target

Study Summary

The purpose of this study is to collect urine samples and dating scan information from women who wish to become pregnant. Urine samples will be tested in the laboratory with the Clearblue Pregnancy Test and the results correlated with volunteer information.

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2010-01
Est. Completion 2011-07
SPD Development Company Limited

3 total trials

What the finished NCT01077583 record still lists

NCT01077583 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01077583 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01077583 about?

NCT01077583 is a clinical study titled "Performance Evaluation Study for Clearblue Pregnancy Test". The purpose of this study is to collect urine samples and dating scan information from women who wish to become pregnant. Urine samples will be tested in the laboratory with the Clearblue Pregnancy Test and the results correlated with volunteer information.

What is the current status of trial NCT01077583?

This trial is currently completed. The enrollment target is 800 participants. The study started on 2010-01. Estimated completion is 2011-07.

Who is sponsoring clinical trial NCT01077583?

This trial is sponsored by SPD Development Company Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01077583, the US trial registry maintained by the National Library of Medicine. NCT01077583 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.